Target intelligence / Profile preview

Hydroxy-delta-5-steroid dehydrogenase, 3 beta, pseudogene 5 (HSD3BP5)

Target: HSD3BP5
Molecular classification: Pseudogene

Overview

HSD3BP5 is annotated as a pseudogene in the human genome. It shares sequence similarity with active 3β-hydroxysteroid dehydrogenase (3β-HSD, such as HSD3B1 and HSD3B2) genes responsible for catalyzing a key step in steroid hormone biosynthesis, but HSD3BP5 does not encode a functional enzyme. Pseudogenes like HSD3BP5 may be remnants of gene duplications or evolutionary events and are usually not transcribed or translated into functional proteins. Therefore, it does not serve as a therapeutic target, has no known physiological or pathological role, and is not a drug target.

Beyond the preview

Go deeper on Hydroxy-delta-5-steroid dehydrogenase, 3 beta, pseudogene 5 (HSD3BP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydroxy-delta-5-steroid dehydrogenase, 3 beta, pseudogene 5 (HSD3BP5).

Explore the full profile